PriceTargets.com logo

Soliton - SOLY Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$22.58 As of 12/16/2021 01:00 AM ET
+0 (0.00%)
Get New Soliton Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SOLY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SOLY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Soliton in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $22.58.

This chart shows the closing price for SOLY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Soliton. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/1/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/2/2021Roth CapitalDowngradeBuy ➝ NeutralLow
5/19/2021Cantor FitzgeraldReiterated RatingOverweight ➝ Neutral$25.00 ➝ $22.60Low
5/13/2021Cantor FitzgeraldDowngradeOverweight ➝ Neutral$25.00 ➝ $22.60Low
5/10/2021Maxim GroupDowngradeBuy ➝ HoldLow
3/5/2021Maxim GroupReiterated RatingBuy$25.00High
2/8/2021Maxim GroupBoost TargetBuy$22.00 ➝ $25.00Medium
2/2/2021Cantor FitzgeraldBoost TargetOverweight$12.00 ➝ $20.00Low
7/15/2020Cantor FitzgeraldInitiated CoverageOverweight$12.00High
7/2/2020Maxim GroupReiterated RatingBuy$22.00Low
6/16/2020Roth CapitalBoost Target$14.00 ➝ $16.00High
4/3/2020Maxim GroupReiterated RatingBuy$22.00High
3/27/2020Roth CapitalInitiated CoverageBuy$14.00Low
3/4/2020Maxim GroupReiterated RatingBuy$22.00Low
12/5/2019Maxim GroupInitiated CoverageBuy$22.00Medium
(Data available from 4/24/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/24/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Soliton logo
Soliton, Inc. is a medical development company, which engages in the development of healthcare technological devices for medical and cosmetic treatments. Its technology platform include Rapid Acoustic Pulse, a device uses rapid pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue. The firm is also in the pre-revenue stage with its first products being developed for the removal of tattoos and the reduction of cellulite. The company was founded by Walter V. Klemp and Christopher Capelli on March 27, 2012 and is headquartered in Houston, TX.
Read More

Today's Range

Now: $22.58
Low: $22.58
High: $22.58

50 Day Range

MA: $21.55
Low: $20.10
High: $22.58

52 Week Range

Now: $22.58
Low: $7.40
High: $22.60

Volume

N/A

Average Volume

347,827 shs

Market Capitalization

$487.66 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.19

Frequently Asked Questions

What sell-side analysts currently cover shares of Soliton?

The following equities research analysts have issued research reports on Soliton in the last year:
View the latest analyst ratings for SOLY.

What is the current price target for Soliton?

0 Wall Street analysts have set twelve-month price targets for Soliton in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Soliton in the next year.
View the latest price targets for SOLY.

What is the current consensus analyst rating for Soliton?

Soliton currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for SOLY.

What other companies compete with Soliton?

Other companies that are similar to Soliton include Orthofix Medical, Iradimed, OraSure Technologies, Beauty Health and Surmodics. Learn More about companies similar to Soliton.

How do I contact Soliton's investor relations team?

Soliton's physical mailing address is 5304 ASHBROOK DRIVE, HOUSTON TX, 77081. The company's listed phone number is (844) 705-4866 and its investor relations email address is [email protected]. The official website for Soliton is www.soliton.com. Learn More about contacing Soliton investor relations.